News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Hidehito Horinouchi: Taletrectinib in ROS1 plus Non–Small Cell Lung Cancer
Hidehito Horinouchi/X
Apr 6, 2025, 05:33

Hidehito Horinouchi: Taletrectinib in ROS1 plus Non–Small Cell Lung Cancer

Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, shared on X about a recent paper by Maurice Pérol:

“TRUST: Taletrectinib in ROS1+ NSCLC

TKI-naïve/pretreated: ORR 88.8/55.8%, Intracranial-ORR 76.5/65.6%, mPFS 45.6/9.7mo.”

“Taletrectinib in ROS1+ Non–Small Cell Lung Cancer: TRUST.”

Authors: Maurice Pérol, Wei Li, Nathan A. Pennell, Geoffrey Liu, Yuichiro Ohe, Filippo De Braud, Misako Nagasaka, Enriqueta Felip, Anwen Xiong, Yongchang Zhang, Huijie Fan, Xicheng Wang, Shuanglian Li, Rose K. Lai, Feiwu Ran, Xianyu Zhang, Wenfeng Chen, Lyudmila Bazhenova, Caicun Zhou.

Hidehito Horinouchi: Taletrectinib in ROS1 plus Non–Small Cell Lung Cancer

cancer Enriqueta Felip Filippo de Braud Geoffrey Liu Hidehito Horinouchi Maurice Pérol Misako Nagasaka Nathan A.Pennell non small cell lung cancer OncoDaily Oncology TRUST trial Wei Li Yuichiro Ohe
Special Coverage
Blog
Apr 6, 2025, 05:33
Hidehito Horinouchi: Taletrectinib in ROS1 plus Non–Small Cell Lung Cancer
Blog
Apr 6, 2025, 05:27
Sakditad Saowapa: Delighted to share that my abstract got accepted for ISTH 2025
Blog
Apr 6, 2025, 05:12
Rahul Banerjee: Who needs custom IL-18 armoring if you can give off-the-shelf IL-18 that sticks around?
Blog
Apr 6, 2025, 05:06
IPOS is welcoming its first member from Bolivia
Blog
Apr 6, 2025, 04:41
Catherine Alix-Panabières: Delighted to have delivered The Conference at the Intensive Lessons of Digestive Cancerology
Career
Apr 6, 2025, 03:46
Honoring Professor Nicholas Anthony Othieno-Abinya: 2025 iCMLf Prize Recipient - International CML Foundation
Insight
Apr 6, 2025, 01:57
Bishal Gyawali: Treatment Innovations in Pancreatic Cancer
Immune Oncology
Apr 6, 2025, 01:44
Immunotherapy for Skin Cancer: Types, Success Rate, Side Effects and More
Blog
Apr 6, 2025, 00:56
Emad Shash: Call for abstract submission for the 4th Shefa Al Orman Hospital Annual Scientific Conference is open
Insight
Apr 5, 2025, 20:21
Yelak Biru: Phase 3 trials supporting FDA approvals in myeloma
Blog
Apr 5, 2025, 20:01
Why do we need another cancer foundation? - Foundation for Autoimmune Cancer Support
Insight
Apr 5, 2025, 19:46
Loay Kassem: Artificial intelligence could beat humans in the early detection of breast cancer